BioCircle
The computed 12-month bankruptcy probability of BioCircle is 1.7% (moderate). The 2024 annual accounts show negative equity (€-37k) and a net result of €72k. Equity remains stable across the filed fiscal years (±0.3% per year). Its solvency ranks better than 27% of 36 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-37k |
| Net result | €72k |
| Better than sector | 27% |
| Active | 5 yrs |
Mixed profile: strong on stability, weaker on profitability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -4.0% | 19.4% | |
| Net result | €72k | €-3k | |
| Equity | €-37k | €96k | |
| Gross operating margin | €108k | €80k | |
| Total assets | €915k | €2.09M |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | - |
| Net profit | €72k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €915k |
| Equity | €-37k |
| Debt | €952k |
| of which ≤ 1y | €163k |
| of which > 1y | €789k |
| Working capital | €752k |
| Employees (FTE) | 0.0 |
| 2024 | |
|---|---|
| Current ratio | 5.62 |
| Quick ratio | 5.62 |
| Working capital ratio | 82.2% |
| Solvency | -4.0% |
| Debt / equity | -25.75 |
| Long-term debt ratio | -21.35 |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | 7.8% |
| ROE | -194.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €915k |
| Fixed assets | 21/28 | €0 |
| Tangible fixed assets | 22/27 | €0 |
| Current assets | 29/58 | €915k |
| Amounts receivable within one year | 40/41 | €915k |
| Cash & bank | 54/58 | €169 |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €915k |
| Equity | 10/15 | €-37k |
| Contributions / capital | 10/11 | €105k |
| Accumulated profits (losses) | 14 | €-142k |
| Amounts payable | 17/49 | €952k |
| Amounts payable after one year | 17 | €789k |
| Amounts payable within one year | 42/48 | €163k |
| Trade debts payable within one year | 44 | €15k |
| Income statement | ||
| Gross operating margin | 9900 | €108k |
| Operating result | 9901 | €107k |
| Financial income | 75 | €16 |
| Financial charges | 65 | €35k |
| Result before taxes | 9903 | €72k |
| Net result for the period | 9904 | €72k |
| Result to be appropriated | 9905 | €72k |
| NACE primary | 38210 |
| Legal form | Private limited company(610) |
| Incorporation | 28-01-2021 |
| Status | Active |
| Postal code | 3210 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24063A0006/00L000 | Flanders | 1,488 m² | 1 · 196 m² | 7.7 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
29-08-2022 Ghislain Collin appointed as director correction
- Ghislain Collin, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ghislain Collin",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": "niet_statutair",
"compensated": false,
"effective_date": "2022-06-17",
"evidence_quote": "Bij beraadslaging dd. 17/06/2022 heeft de algemene vergadering over de volgende zaken vergaderd en als volgt beslist.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Leuven",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2022-08-29",
"filing_date": "2022-08-18",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2022-06-17",
"unanimous": null
}
],
"is_correction": true,
"subject_company": {
"kbo": "0762.643.692",
"name_full": "BioCircle",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Ronald Daene",
"org_rep_person_name": null,
"person_role_at_subject": "Bestuurder"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}02-05-2022 Capital increase of €5,000 to €5,000
- €0 → €5.000
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 5000.0,
"delta_eur": 5000.0,
"before_eur": 0.0,
"_arith_derived": "before",
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": 5,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1000.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 5000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "create"
}
],
"notary": {
"name": "Yorik DESMYTTERE",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2022-05-02",
"filing_date": "2022-04-28",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2022-04-21",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0762.643.692",
"name_full": "BioCircle",
"legal_form": "B.V.",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"volmacht",
"de geco\u00F6rdineerde tekst van statuten"
],
"shareholders_after": [],
"share_classes_after": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | BioCircle |